Yayla, U. Et Al. 2023. Real-World Outcomes of Intravitreal Anti-Vascular Endothelial Growth Factor Treatment for Diabetic Macular Edema in Türkiye: MARMASIA Study Group Report No. 1.. Turkish journal of ophthalmology , vol.53, no.6 , 356-368.

Yayla, U., Sevik, M. O., Karabaş, V. L., Şahin, Ö., Özkaya, A., Yenerel, N. M., ... Açıkalın Öncel, B.(2023). Real-World Outcomes of Intravitreal Anti-Vascular Endothelial Growth Factor Treatment for Diabetic Macular Edema in Türkiye: MARMASIA Study Group Report No. 1.. Turkish journal of ophthalmology , vol.53, no.6, 356-368.

Yayla, Uğur Et Al. "Real-World Outcomes of Intravitreal Anti-Vascular Endothelial Growth Factor Treatment for Diabetic Macular Edema in Türkiye: MARMASIA Study Group Report No. 1.," Turkish journal of ophthalmology , vol.53, no.6, 356-368, 2023

Yayla, Uğur Et Al. "Real-World Outcomes of Intravitreal Anti-Vascular Endothelial Growth Factor Treatment for Diabetic Macular Edema in Türkiye: MARMASIA Study Group Report No. 1.." Turkish journal of ophthalmology , vol.53, no.6, pp.356-368, 2023

Yayla, U. Et Al. (2023) . "Real-World Outcomes of Intravitreal Anti-Vascular Endothelial Growth Factor Treatment for Diabetic Macular Edema in Türkiye: MARMASIA Study Group Report No. 1.." Turkish journal of ophthalmology , vol.53, no.6, pp.356-368.

@article{article, author={Uğur Yayla Et Al. }, title={Real-World Outcomes of Intravitreal Anti-Vascular Endothelial Growth Factor Treatment for Diabetic Macular Edema in Türkiye: MARMASIA Study Group Report No. 1.}, journal={Turkish journal of ophthalmology}, year=2023, pages={356-368} }